Muir-Torre syndrome

American Journal of Clinical Dermatology

Volumn 8, Issue 5, 2007, Pages 315-319

  Lachiewicz, Anne M ^a   Wilkinson, Todd M ^a   Groben, Pamela ^a   Ollila, David W ^a   Thomas, Nancy E ^a  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DNA; PROTEIN MLH1; PROTEIN MSH2; PROTEIN MUTL;

ADULT; ARTICLE; AUTOSOMAL DOMINANT DISORDER; CANCER FAMILY; CANCER PATIENT; CANCER RISK; CASE REPORT; COLON CANCER; COLON TUMOR; COLONOSCOPY; COLORECTAL CANCER; DIGESTIVE SYSTEM CANCER; DISEASE COURSE; DISEASE PREDISPOSITION; ENDOMETRIUM; FAMILY; FAMILY HISTORY; GENE; GENE MUTATION; GENODERMATOSIS; HIGH RISK PATIENT; HISTORY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; KERATOACANTHOMA; MALE; MEDICAL EXPERT; MICROSATELLITE INSTABILITY; MISMATCH REPAIR; MUIR TORRE SYNDROME; PHYSICAL EXAMINATION; PHYSICIAN; PRIORITY JOURNAL; SAMPLING; SCREENING TEST; SEBACEOUS CARCINOMA; SEBACEOUS CYST; SKIN EXAMINATION; SPLEEN; TRANSVAGINAL ECHOGRAPHY; URINALYSIS; UROGENITAL TRACT CANCER;

EID: 35148827627     PISSN: 11750561     EISSN: None     Source Type: Journal    
DOI: 10.2165/00128071-200708050-00008     Document Type: Article

References (30)

1. Schwartz RA, Torre DP. The Muir-Torre syndrome: a 25-year retrospect. J Am Acad Dermatol 1995 Jul; 33 (1): 90-104
2. Stewart WM, Lauret P, Hemet J, et al. Multiple kerato-acanthomas and visceral carcinomas: Torre's syndrome [in French]. Ann Dermatol Venereol 1977 Oct; 104 (10): 622-6
3. Ponti G, Ponz de Leon M. Muir-Torre syndrome. Lancet Oncol 2005 Dec; 6 (12): 980-7
4. Cohen PR, Kohn SR, Davis DA, et al. Muir-Torre syndrome. Dermatol Clin 1995 Jan; 13 (1): 79-89
5. Akhtar S, Oza KK, Khan SA, et al. Muir-Torre syndrome: case report of a patient with concurrent jejunal and ureteral cancer and a review of the literature. J Am Acad Dermatol 1999 Nov; 41 (5 Pt 1): 681-6
6. Bailet JW, Zimmerman MC, Arnstein DP, et al. Sebaceous carcinoma of the head and neck: case report and literature review. Arch Otolaryngol Head Neck Surg 1992 Nov; 118 (11): 1245-9
7. Wick MR, Goellner JR, Wolfe 3rd JT, et al. Adnexal carcinomas of the skin. II: extraocular sebaceous carcinomas. Cancer 1985 Sep 1; 56 (5): 1163-72
8. Nelson BR, Hamlet KR, Gillard M, et al. Sebaceous carcinoma. J Am Acad Dermatol 1995 Jul; 33 (1): 1-15, quiz 16-8
9. Snow SN, Larson PO, Lucarelli MJ, et al. Sebaceous carcinoma of the eyelids treated by Mohs micrographic surgery: report of nine cases with review of the literature. Dermatol Surg 2002 Jul; 28 (7): 623-31
10. Conill C, Toscas I, Morilla I, et al. Radiation therapy as a curative treatment in extraocular sebaceous carcinoma. Br J Dermatol 2003 Aug; 149 (2): 441-2
11. Pardo FS, Wang CC, Albert D, et al. Sebaceous carcinoma of the ocular adnexa: radiotherapeutic management. Int J Radiat Oncol Biol Phys 1989 Sep; 17 (3): 643-7
12. Tan O, Ergen D, Arslan R. Sebaceous carcinoma on the scalp. Dermatol Surg 2006 Oct; 32 (10): 1290-3
13. Rütten A, Burgdorf W, Hugel H, et al. Cystic sebaceous tumors as marker lesions for the Muir-Torre syndrome: a histopathologic and molecular genetic study. Am J Dermatopathol 1999 Oct; 21 (5): 405-13
14. Misago N, Narisawa Y. Sebaceous neoplasms in Muir-Torre syndrome. Am J Dermatopathol 2000 Apr; 22 (2): 155-61
15. Misago N, Narisawa Y. Cytokeratin 15 expression in neoplasms with sebaceous differentiation. J Cutan Pathol 2006 Sep; 33 (9): 634-41
16. Lindor NM, Petersen GM, Hadley DW, et al. Recommendations for the care of individuals with an inherited predisposition to Lynch syndrome: a systematic review. JAMA 2006 Sep 27; 296 (12): 1507-17
17. Boardman LA. Heritable colorectal cancer syndromes: recognition and preventive management. Gastroenterol Clin North Am 2002 Dec; 31 (4): 1107-31
18. Cruz-Correa M, Giardiello FM. Diagnosis and management of hereditary colon cancer. Gastroenterol Clin North Am 2002 Jun; 31 (2): 537-49, x
19. Spielvogel RL, DeVillez RL, Roberts LC. Oral isotretinoin therapy for familial Muir-Torre syndrome. J Am Acad Dermatol 1985 Mar; 12 (3): 475-80
20. Marcusson JA, Bjarnason B, Ros AM. Isotretinoin for sebaceous skin lesions in Muir-Torre syndrome: a case report. Acta Derm Venereol 1998 Nov; 78 (6): 479-80
21. Graefe T, Wollina U, Schulz H, et al. Muir-Torre syndrome: treatment with isotretinoin and interferon alpha-2a can prevent tumour development. Dermatology 2000; 200 (4): 331-3
22. Vasen HF, Watson P, Mecklin JP, et al. New clinical criteria for hereditary nonpolyposis colorectal cancer (HNPCC, Lynch syndrome) proposed by the International Collaborative Group on HNPCC. Gastroenterology 1999; 116 (6): 1453-6
23. Kruse R, Ruzicka T. DNA mismatch repair and the significance of a sebaceous skin tumor for visceral cancer prevention. Trends Mol Med 2004; 10 (3): 136-41
24. Mangold E, Rahner N, Friedrichs N, et al. MSH6 mutation in Muir-Torre syndrome: could this be a rare finding? Br J Dermatol 2007 Jan; 156 (1): 158-62
25. Ponti G, Losi L, Di Gregorio C, et al. Identification of Muir-Torre syndrome among patients with sebaceous tumors and keratoacanthomas: role of clinical features, microsatellite instability, and immunohistochemistry. Cancer 2005 Mar 1; 103 (5): 1018-25
26. Ponti G, Ponz de Leon M, Maffei S, et al. Attenuated familial adenomatous polyposis and Muir-Torre syndrome linked to compound biallelic constitutional MYH gene mutations. Clin Genet 2005 Nov; 68 (5): 442-7
27. Goldberg M, Rummelt C, Foja S, et al. Different genetic pathways in the development of periocular sebaceous gland carcinomas in presumptive Muir-Torre syndrome patients. Hum Mutat 2006 Feb; 27 (2): 155-62
28. Cohen PR, Kohn SR, Kurzrock R. Association of sebaceous gland tumors and internal malignancy: the Muir-Torre syndrome. Am J Med 1991 May; 90 (5): 606-13
29. Mathiak M, Rütten A, Mangold E, et al. Loss of DNA mismatch repair proteins in skin tumors from patients with Muir-Torre syndrome and MSH2 or MLH1 germline mutations: establishment of immunohistochemical analysis as a screening test. Am J Surg Pathol 2002 Mar; 26 (3): 338-43
30. Hampel H, Stephens JA, Pukkala E, et al. Cancer risk in hereditary nonpolyposis colorectal cancer syndrome: later age of onset. Gastroenterology 2005 Aug; 129 (2): 415-21